Llin\u00e1s, R. R. The contribution of Santiago Ram\u00f3n y Cajal to functional neuroscience. Nat. Rev. Neurosci. 4, 77\u201380 (2003).<\/p>\n
Article<\/a>\u00a0 McCulloch, E. A. & Till, J. E. Perspectives on the properties of stem cells. Nat. Med. 11, 1026\u20131028 (2005).<\/p>\n Article<\/a>\u00a0 Kumar, T. et al. A spatially resolved single-cell genomic atlas of the adult human breast. Nature 620, 181\u2013191 (2023).<\/p>\n Article<\/a>\u00a0 Sikkema, L. et al. An integrated cell atlas of the lung in health and disease. Nat. Med. 29, 1563\u20131577 (2023).<\/p>\n Article<\/a>\u00a0 Barkley, D. et al. Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment. Nat. Genet. 54, 1192\u20131201 (2022).<\/p>\n Article<\/a>\u00a0 Gavish, A. et al. Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours. Nature 618, 598\u2013606 (2023). The Barkley et al. and Gavish et al. studies define meta programs of gene expression across many tumour types, showing that cancer cell states tend to be shared across tumours.<\/p>\n Article<\/a>\u00a0 Gargiulo, G., Serresi, M. & Marine, J.-C. Cell states in cancer: drivers, passengers, and trailers. Cancer Discov. 14, 610\u2013614 (2024).<\/p>\n Article<\/a>\u00a0 Zeng, H. What is a cell type and how to define it? Cell 185, 2739\u20132755 (2022).<\/p>\n Article<\/a>\u00a0 Velten, L. et al. Human haematopoietic stem cell lineage commitment is a continuous process. Nat. Cell Biol. 19, 271\u2013281 (2017).<\/p>\n Article<\/a>\u00a0 Pastushenko, I. et al. Identification of the tumour transition states occurring during EMT. Nature 556, 463\u2013468 (2018).<\/p>\n Article<\/a>\u00a0 Ladewig, J., Koch, P. & Br\u00fcstle, O. Leveling Waddington: the emergence of direct programming and the loss of cell fate hierarchies. Nat. Rev. Mol. Cell Biol. 14, 225\u2013236 (2013).<\/p>\n Article<\/a>\u00a0 West-Eberhard, M. J. Developmental Plasticity and Evolution (Oxford Univ. Press, 2003).<\/p>\n Levis, N. A. & Pfennig, D. W. Evaluating \u2018plasticity-first\u2019 evolution in nature: key criteria and empirical approaches. Trends Ecol. Evol. 31, 563\u2013574 (2016).<\/p>\n Article<\/a>\u00a0 Frank, S. A. & Yanai, I. The origin of novel traits in cancer. Trends Cancer 10, 880\u2013892 (2024). This article argues that novel traits in cancer can originate through initially non-heritable phenotypic variation, challenging the classic gene-centric view.<\/p>\n Article<\/a>\u00a0 Frank, S. A. How cancer arises: genetics releases, plasticity creates, genetics stabilizes. Proc. Natl Acad. Sci. USA 122, e2505377122 (2025).<\/p>\n Article<\/a>\u00a0 Frank, S. A. & Rosner, M. R. Nonheritable cellular variability accelerates the evolutionary processes of cancer. PLoS Biol. 10, e1001296 (2012).<\/p>\n Article<\/a>\u00a0 Gupta, P. B. et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, 633\u2013644 (2011).<\/p>\n Article<\/a>\u00a0 Kaern, M., Elston, T. C., Blake, W. J. & Collins, J. J. Stochasticity in gene expression: from theories to phenotypes. Nat. Rev. Genet. 6, 451\u2013464 (2005).<\/p>\n Article<\/a>\u00a0 Kreso, A. et al. Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 339, 543\u2013548 (2013).<\/p>\n Article<\/a>\u00a0 Marsolier, J. et al. H3K27me3 conditions chemotolerance in triple-negative breast cancer. Nat. Genet. 54, 459\u2013468 (2022).<\/p>\n Article<\/a>\u00a0 Oren, Y. et al. Cycling cancer persister cells arise from lineages with distinct programs. Nature 596, 576\u2013582 (2021).<\/p>\n Article<\/a>\u00a0 Goyal, Y. et al. Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells. Nature 620, 651\u2013659 (2023). This paper shows that genetically identical cancer cells can give rise to distinct drug-resistant phenotypes, which are largely predetermined by intrinsic cell-state differences before treatment.<\/p>\n Article<\/a>\u00a0 Shaffer, S. M. et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546, 431\u2013435 (2017). This landmark study demonstrates that non-genetic drug resistance arises from rare cells that transiently express resistance-associated genes.<\/p>\n Article<\/a>\u00a0 Rosano, D. et al. Long-term multimodal recording reveals epigenetic adaptation routes in dormant breast cancer cells. Cancer Discov. 14, 866\u2013889 (2024).<\/p>\n Article<\/a>\u00a0 Rehman, S. K. et al. Colorectal cancer cells enter a diapause-like DTP state to survive chemotherapy. Cell 184, 226\u2013242.e21 (2021).<\/p>\n Article<\/a>\u00a0 Dhimolea, E. et al. An embryonic diapause-like adaptation with suppressed myc activity enables tumor treatment persistence. Cancer Cell 39, 240\u2013256.e11 (2021).<\/p>\n Article<\/a>\u00a0 Hastings, J. F. et al. Memory of stochastic single-cell apoptotic signaling promotes chemoresistance in neuroblastoma. Sci. Adv. 9, eabp8314 (2023).<\/p>\n Article<\/a>\u00a0 Sharma, S. V. et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69\u201380 (2010). This seminal work discovers a new mechanism of drug resistance, in which cancer cells can transiently and reversibly enter a drug-tolerant state through non-genetic changes.<\/p>\n Article<\/a>\u00a0 Russo, M. et al. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities. Nat. Rev. Cancer 24, 694\u2013717 (2024).<\/p>\n Article<\/a>\u00a0 Marine, J.-C., Dawson, S.-J. & Dawson, M. A. Non-genetic mechanisms of therapeutic resistance in cancer. Nat. Rev. Cancer 20, 743\u2013756 (2020).<\/p>\n Article<\/a>\u00a0 Brock, A., Chang, H. & Huang, S. Non-genetic heterogeneity \u2014 a mutation-independent driving force for the somatic evolution of tumours. Nat. Rev. Genet. 10, 336\u2013342 (2009).<\/p>\n Article<\/a>\u00a0 Pisco, A. O. et al. Non-Darwinian dynamics in therapy-induced cancer drug resistance. Nat. Commun. 4, 2467 (2013).<\/p>\n Article<\/a>\u00a0 Tong, X. et al. Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer. Cancer Cell 42, 413\u2013428.e7 (2024).<\/p>\n Article<\/a>\u00a0 Chan, J. M. et al. Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling. Science 377, 1180\u20131191 (2022).<\/p>\n Article<\/a>\u00a0 Tsoi, J. et al. Multi-stage differentiation defines melanoma subtypes with differential vulnerability to drug-induced iron-dependent oxidative stress. Cancer Cell 33, 890\u2013904.e5 (2018).<\/p>\n Article<\/a>\u00a0 Shibue, T. & Weinberg, R. A. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat. Rev. Clin. Oncol. 14, 611\u2013629 (2017).<\/p>\n Article<\/a>\u00a0 Oliveira, E. A. et al. Epigenetic heritability of cell plasticity drives cancer drug resistance through a one-to-many genotype-to-phenotype paradigm. Cancer Res. 85, 2921\u20132938 (2025).<\/p>\n Article<\/a>\u00a0 Marusyk, A., Janiszewska, M. & Polyak, K. Intratumor heterogeneity: the Rosetta stone of therapy resistance. Cancer Cell 37, 471\u2013484 (2020).<\/p>\n Article<\/a>\u00a0 Marjanovic, N. D. et al. Emergence of a high-plasticity cell state during lung cancer evolution. Cancer Cell 38, 229\u2013246.e13 (2020).<\/p>\n Article<\/a>\u00a0 Mzoughi, S. et al. Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer. Nat. Genet. 57, 402\u2013412 (2025).<\/p>\n Article<\/a>\u00a0 Moorman, A. et al. Progressive plasticity during colorectal cancer metastasis. Nature 637, 947\u2013954 (2025). This study uncovers extreme phenotypic plasticity driving metastasis in colorectal cancer, in which intestinal cells undergo dedifferentiation through a highly plastic oncofetal state and adopt squamous and neuroendocrine-like states.<\/p>\n Article<\/a>\u00a0 Fran\u00e7a, G. S. et al. Cellular adaptation to cancer therapy along a resistance continuum. Nature 631, 876\u2013883 (2024). This work introduced the concept of the \u2018resistance continuum\u2019, revealing that drug resistance emerges through progressive adaptive cell-state transitions towards increased fitness, underpinned by phenotypic plasticity and chromatin reprogramming for stress response.<\/p>\n Article<\/a>\u00a0 Vander Velde, R. et al. Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures. Nat. Commun. 11, 2393 (2020). This work introduced the notion that resistance to targeted therapy arises through a gradual process of adaptation explained by both genetic and non-genetic mechanisms.<\/p>\n Article<\/a>\u00a0 Li, J. et al. AP-1 mediates cellular adaptation and memory formation. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-026-70862-w<\/a> (2026). This study reveals that melanoma cells develop therapy resistance by forming AP-1-dependent cellular memories, suggesting heritable adaptive genome reprogramming.<\/p>\n Fennell, K. A. et al. Non-genetic determinants of malignant clonal fitness at single-cell resolution. Nature 601, 125\u2013131 (2022).<\/p>\n Article<\/a>\u00a0 Morgan, D., Gardner, A. L. & Brock, A. Lineage tracing reveals clone-specific responses to doxorubicin in triple-negative breast cancer. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.03.18.643980<\/a> (2025).<\/p>\n Lee, P., Chandel, N. S. & Simon, M. C. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat. Rev. Mol. Cell Biol. 21, 268\u2013283 (2020).<\/p>\n Article<\/a>\u00a0 Jacob, F. & Monod, J. Genetic regulatory mechanisms in the synthesis of proteins. J. Mol. Biol. 3, 318\u2013356 (1961).<\/p>\n Article<\/a>\u00a0 Davidson, E. H. Emerging properties of animal gene regulatory networks. Nature 468, 911\u2013920 (2010).<\/p>\n Article<\/a>\u00a0 Chalancon, G. et al. Interplay between gene expression noise and regulatory network architecture. Trends Genet. 28, 221\u2013232 (2012).<\/p>\n Article<\/a>\u00a0 Levine, M. & Davidson, E. H. Gene regulatory networks for development. Proc. Natl Acad. Sci. USA 102, 4936\u20134942 (2005).<\/p>\n Article<\/a>\u00a0 Braun, E. The unforeseen challenge: from genotype-to-phenotype in cell populations. Rep. Prog. Phys. 78, 036602 (2015). This work proposes a unifying framework in which cell states can emerge from exploratory dynamics of gene regulation, offering a transformative view of how cells can adapt to unfamiliar environmental conditions.<\/p>\n Article<\/a>\u00a0 Shomar, A., Barak, O. & Brenner, N. Cancer progression as a learning process. iScience 25, 103924 (2022). This paper proposes that cellular adaptation in cancer arises through a process analogous to cellular learning facilitated by transcription factors that work as regulatory hubs.<\/p>\n Article<\/a>\u00a0 Freddolino, L., Yang, J., Momen-Roknabadi, A. & Tavazoie, S. Stochastic tuning of gene expression enables cellular adaptation in the absence of pre-existing regulatory circuitry. eLife 7, e31867 (2018). This study proposed a stochastic tuning mechanism by which cells adapt to novel environments through fitness-driven adjustments of individual gene expression.<\/p>\n Article<\/a>\u00a0 Momen-Roknabadi, A., Oikonomou, P. & Tavazoie, S. Adaptation by stochastic tuning of gene expression in mammalian cells. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.05.07.651953<\/a> (2025).<\/p>\n Schreier, H. I., Soen, Y. & Brenner, N. Exploratory adaptation in large random networks. Nat. Commun. 8, 14826 (2017).<\/p>\n Article<\/a>\u00a0 Baron, M. et al. The stress-like cancer cell state is a consistent component of tumorigenesis. Cell Syst 11, 536\u2013546.e7 (2020). This study describes a conserved stress-like cancer cell state in tumorigenesis, characterized by enhanced tumour seeding and drug tolerance.<\/p>\n Article<\/a>\u00a0 Vihervaara, A., Duarte, F. M. & Lis, J. T. Molecular mechanisms driving transcriptional stress responses. Nat. Rev. Genet. 19, 385\u2013397 (2018).<\/p>\n Article<\/a>\u00a0 Greenberg, M. E. & Ziff, E. B. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311, 433\u2013438 (1984).<\/p>\n Article<\/a>\u00a0 Baudre, L. et al. Characterization of drug-tolerant persister cells in triple-negative breast cancer identifies a shared persistence program across treatments and patients. Cancer Res. 86, 802\u2013817 (2026).<\/p>\n Diao, S. et al. Lineage plasticity of the integrated stress response is a hallmark of cancer evolution. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.02.10.637516<\/a> (2025).<\/p>\n D\u2019Urso, A. & Brickner, J. H. Mechanisms of epigenetic memory. Trends Genet. 30, 230\u2013236 (2014).<\/p>\n Article<\/a>\u00a0 Owen, J. A., Osmanovi\u0107, D. & Mirny, L. Design principles of 3D epigenetic memory systems. Science 382, eadg3053 (2023).<\/p>\n Article<\/a>\u00a0 Espinosa-Mart\u00ednez, M., Alc\u00e1zar-Fabra, M. & Landeira, D. The molecular basis of cell memory in mammals: the epigenetic cycle. Sci. Adv. 10, eadl3188 (2024).<\/p>\n Article<\/a>\u00a0 Tian, C. et al. Impaired histone inheritance promotes tumor progression. Nat. Commun. 14, 3429 (2023).<\/p>\n Article<\/a>\u00a0 Zhao, S., Allis, C. D. & Wang, G. G. The language of chromatin modification in human cancers. Nat. Rev. Cancer 21, 413\u2013430 (2021).<\/p>\n Article<\/a>\u00a0 Shaulian, E. & Karin, M. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4, E131\u2013E136 (2002). This seminal review discusses the key functional and mechanistic properties of the AP-1 family members.<\/p>\n Article<\/a>\u00a0 Eferl, R. & Wagner, E. F. AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859\u2013868 (2003).<\/p>\n Article<\/a>\u00a0 Chiu, R. et al. The c-Fos protein interacts with c-Jun\/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 54, 541\u2013552 (1988).<\/p>\n Article<\/a>\u00a0 Cohen, D. R., Ferreira, P. C., Gentz, R., Franza, B. R. Jr & Curran, T. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. Genes Dev. 3, 173\u2013184 (1989).<\/p>\n Article<\/a>\u00a0 van Dam, H. & Castellazzi, M. Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene 20, 2453\u20132464 (2001).<\/p>\n Article<\/a>\u00a0 Bejjani, F., Evanno, E., Zibara, K., Piechaczyk, M. & Jariel-Encontre, I. The AP-1 transcriptional complex: local switch or remote command? Biochim. Biophys. Acta Rev. Cancer 1872, 11\u201323 (2019).<\/p>\n Article<\/a>\u00a0 Seo, J. et al. AP-1 subunits converge promiscuously at enhancers to potentiate transcription. Genome Res. 31, 538\u2013550 (2021). This study maps the genome-wide binding of AP-1 subunits and reveals promiscuous binding at genomic hotspots, suggesting this is key for regulating cell-type-specific gene expression and environmental responses.<\/p>\n Article<\/a>\u00a0 Vierbuchen, T. et al. AP-1 transcription factors and the BAF complex mediate signal-dependent enhancer selection. Mol. Cell 68, 1067\u20131082.e12 (2017).<\/p>\n Article<\/a>\u00a0 Zhou, H. et al. Frequency and distribution of AP-1 sites in the human genome. DNA Res. 12, 139\u2013150 (2005).<\/p>\n Article<\/a>\u00a0 Fonseca, G. J. et al. Diverse motif ensembles specify non-redundant DNA binding activities of AP-1 family members in macrophages. Nat. Commun. 10, 414 (2019).<\/p>\n Article<\/a>\u00a0 Hess, J., Angel, P. & Schorpp-Kistner, M. AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117, 5965\u20135973 (2004).<\/p>\n Article<\/a>\u00a0 Markov, G. J. et al. AP-1 is a temporally regulated dual gatekeeper of reprogramming to pluripotency. Proc. Natl Acad. Sci. USA 118, e2104841118 (2021).<\/p>\n Article<\/a>\u00a0 Comandante-Lou, N., Baumann, D. G. & Fallahi-Sichani, M. AP-1 transcription factor network explains diverse patterns of cellular plasticity in melanoma cells. Cell Rep. 40, 111147 (2022). This study reveals that the AP-1 transcription factor network determines cellular states in melanoma, showing that the balance among its subunits governs differentiation states and therapy response.<\/p>\n Article<\/a>\u00a0 Kuonen, F. et al. c-FOS drives reversible basal to squamous cell carcinoma transition. Cell Rep. 37, 109774 (2021).<\/p>\n Article<\/a>\u00a0 Li, Y. et al. Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer. Nat. Cancer 2, 49\u201365 (2021).<\/p>\n Article<\/a>\u00a0 Eckert, L. et al. Biochemically plausible models of habituation for single-cell learning. Curr. Biol. 34, 5646\u20135658.e3 (2024).<\/p>\n Article<\/a>\u00a0 Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483\u201316486 (1995).<\/p>\n Article<\/a>\u00a0 Karin, M., Liu, Z. G. & Zandi, E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240\u2013246 (1997).<\/p>\n Article<\/a>\u00a0 Boyle, W. J. et al. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64, 573\u2013584 (1991).<\/p>\n Article<\/a>\u00a0 Reddy, C. E. et al. Multisite phosphorylation of c-Jun at threonine 91\/93\/95 triggers the onset of c-Jun pro-apoptotic activity in cerebellar granule neurons. Cell Death Dis. 4, e852 (2013).<\/p>\n Article<\/a>\u00a0 Pulverer, B. J., Kyriakis, J. M., Avruch, J., Nikolakaki, E. & Woodgett, J. R. Phosphorylation of c-Jun mediated by MAP kinases. Nature 353, 670\u2013674 (1991).<\/p>\n Article<\/a>\u00a0 Waudby, C. A. et al. An intrinsic temporal order of c-JUN N-terminal phosphorylation regulates its activity by orchestrating co-factor recruitment. Nat. Commun. 13, 6133 (2022). This study reveals that multisite phosphorylation of JUN by JNK occurs with distinct temporal kinetics, suggesting a mechanism that switches JUN between repressive and activating states.<\/p>\n Article<\/a>\u00a0 Degefu, Y. N., Bujnowska, M., Baumann, D. G. & Fallahi-Sichani, M. Cell state plasticity emerging from co-regulated, competitive, and configurable interactions within the AP-1 network. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.11.06.686987<\/a> (2025). This study examines AP-1 as a configurable, competitive network whose dimerization dynamics encode discrete cell states and drive melanoma plasticity and therapy resistance.<\/p>\n Biddie, S. C. et al. Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol. Cell 43, 145\u2013155 (2011).<\/p>\n Article<\/a>\u00a0 Wolf, B. K. et al. Cooperation of chromatin remodeling SWI\/SNF complex and pioneer factor AP-1 shapes 3D enhancer landscapes. Nat. Struct. Mol. Biol. 30, 10\u201321 (2023).<\/p>\n Article<\/a>\u00a0 Kamei, Y. et al. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85, 403\u2013414 (1996).<\/p>\n Article<\/a>\u00a0 Naik, S. et al. Inflammatory memory sensitizes skin epithelial stem cells to tissue damage. Nature 550, 475\u2013480 (2017).<\/p>\n Article<\/a>\u00a0 Naik, S. & Fuchs, E. Inflammatory memory and tissue adaptation in sickness and in health. Nature 607, 249\u2013255 (2022).<\/p>\n Article<\/a>\u00a0 Larsen, S. B. et al. Establishment, maintenance, and recall of inflammatory memory. Cell Stem Cell 28, 1758\u20131774.e8 (2021). This study uncovers how inflammatory memory is established and recalled in epidermal stem cells, showing the role of AP-1 in establishing chromatin memory for faster responses to subsequent stresses.<\/p>\n Article<\/a>\u00a0 Nagaraja, S. et al. Epigenetic memory of colitis promotes tumour growth. Nature https:\/\/doi.org\/10.1038\/s41586-026-10258-4<\/a> (2026).<\/p>\n Benhar, M., Engelberg, D. & Levitzki, A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep. 3, 420\u2013425 (2002).<\/p>\n Article<\/a>\u00a0 Savy, T., Flanders, L., Karpanasamy, T., Sun, M. & Gerlinger, M. Cancer evolution: from Darwin to the extended evolutionary synthesis. Trends Cancer 11, 204\u2013215 (2025).<\/p>\n Article<\/a>\u00a0 Suski, J. M., Braun, M., Strmiska, V. & Sicinski, P. Targeting cell-cycle machinery in cancer. Cancer Cell 39, 759\u2013778 (2021).<\/p>\n Article<\/a>\u00a0 Sawyers, C. Targeted cancer therapy. Nature 432, 294\u2013297 (2004).<\/p>\n Article<\/a>\u00a0 Groelly, F. J., Fawkes, M., Dagg, R. A., Blackford, A. N. & Tarsounas, M. Targeting DNA damage response pathways in cancer. Nat. Rev. Cancer 23, 78\u201394 (2023).<\/p>\n Article<\/a>\u00a0 Lee, L. J. et al. Cancer plasticity: the role of mRNA translation. Trends Cancer 7, 134\u2013145 (2021).<\/p>\n Article<\/a>\u00a0 Faubert, B., Solmonson, A. & DeBerardinis, R. J. Metabolic reprogramming and cancer progression. Science 368, eaaw5473 (2020).<\/p>\n Article<\/a>\u00a0 Geffen, Y. et al. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation. Cell 186, 3945\u20133967.e26 (2023).<\/p>\n Article<\/a>\u00a0 Poulikakos, P. I. et al. RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature 480, 387\u2013390 (2011).<\/p>\n Article<\/a>\u00a0 Harmange, G. et al. Disrupting cellular memory to overcome drug resistance. Nat. Commun. 14, 7130 (2023).<\/p>\n Article<\/a>\u00a0 Boumahdi, S. & de Sauvage, F. J. The great escape: tumour cell plasticity in resistance to targeted therapy. Nat. Rev. Drug Discov. 19, 39\u201356 (2020).<\/p>\n Article<\/a>\u00a0 Mu, P. et al. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer. Science 355, 84\u201388 (2017).<\/p>\n Article<\/a>\u00a0 Liau, B. B. et al. Adaptive chromatin remodeling drives glioblastoma stem cell plasticity and drug tolerance. Cell Stem Cell 20, 233\u2013246.e7 (2017).<\/p>\n Article<\/a>\u00a0 Zawistowski, J. S. et al. Enhancer remodeling during adaptive bypass to MEK inhibition is attenuated by pharmacologic targeting of the P-TEFb complex. Cancer Discov. 7, 302\u2013321 (2017).<\/p>\n Article<\/a>\u00a0 Falkenberg, K. J. & Johnstone, R. W. Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nat. Rev. Drug Discov. 13, 673\u2013691 (2014).<\/p>\n Article<\/a>\u00a0 Lasko, L. M. et al. Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours. Nature 550, 128\u2013132 (2017).<\/p>\n Article<\/a>\u00a0 Soragni, A. et al. Acquired resistance in cancer: towards targeted therapeutic strategies. Nat. Rev. Cancer 25, 613\u2013633 (2025).<\/p>\n Article<\/a>\u00a0 Yao, C. D. et al. AP-1 and TGF\u03b2 cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma. Nat. Commun. 11, 5079 (2020).<\/p>\n Article<\/a>\u00a0 Wagner, E. F. & Nebreda, A. R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 9, 537\u2013549 (2009).<\/p>\n Article<\/a>\u00a0 Pei, G. et al. Spatial mapping of transcriptomic plasticity in metastatic pancreatic cancer. Nature 642, 212\u2013221 (2025).<\/p>\n Article<\/a>\u00a0 de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).<\/p>\n Article<\/a>\u00a0 Hunter, M. V. et al. Mechanical confinement governs phenotypic plasticity in melanoma. Nature 647, 517\u2013527 (2025).<\/p>\n Article<\/a>\u00a0 Quintanilla, M., Brown, K., Ramsden, M. & Balmain, A. Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322, 78\u201380 (1986).<\/p>\n Article<\/a>\u00a0 Bala, P. et al. Aberrant cell state plasticity mediated by developmental reprogramming precedes colorectal cancer initiation. Sci. Adv. 9, eadf0927 (2023).<\/p>\n Article<\/a>\u00a0 Balmain, A. The critical roles of somatic mutations and environmental tumor-promoting agents in cancer risk. Nat. Genet. 52, 1139\u20131143 (2020).<\/p>\n Article<\/a>\u00a0 Baggiolini, A. et al. Developmental chromatin programs determine oncogenic competence in melanoma. Science 373, eabc1048 (2021).<\/p>\n Article<\/a>\u00a0 Liu, H., Able, A. J. & Able, J. A. Priming crops for the future: rewiring stress memory. Trends Plant Sci. 27, 699\u2013716 (2022).<\/p>\n Article<\/a>\u00a0 Nadal-Ribelles, M. et al. Transcriptional heterogeneity shapes stress-adaptive responses in yeast. Nat. Commun. 16, 2631 (2025).<\/p>\n Article<\/a>\u00a0 Moye-Rowley, W. S., Harshman, K. D. & Parker, C. S. Yeast YAP1 encodes a novel form of the Jun family of transcriptional activator proteins. Genes Dev. 3, 283\u2013292 (1989).<\/p>\n Article<\/a>\u00a0 Stern, S., Dror, T., Stolovicki, E., Brenner, N. & Braun, E. Genome-wide transcriptional plasticity underlies cellular adaptation to novel challenge. Mol. Syst. Biol. 3, 106 (2007).<\/p>\n Article<\/a>\u00a0 Griffith, E. C., West, A. E. & Greenberg, M. E. Neuronal enhancers fine-tune adaptive circuit plasticity. Neuron 112, 3043\u20133057 (2024). This perspective article links AP-1 with the dynamics of activity-dependent enhancers in fine-tuning neuronal plasticity.<\/p>\n Article<\/a>\u00a0 Pettit, N. L., Yap, E.-L., Greenberg, M. E. & Harvey, C. D. Fos ensembles encode and shape stable spatial maps in the hippocampus. Nature 609, 327\u2013334 (2022).<\/p>\n Article<\/a>\u00a0 Santoni, G. et al. Chromatin plasticity predetermines neuronal eligibility for memory trace formation. Science 385, eadg9982 (2024).<\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n
\n CAS<\/a>\u00a0
\n PubMed<\/a>\u00a0
\n PubMed Central<\/a>\u00a0
\n ADS<\/a>\u00a0
\n
\n Google Scholar<\/a>\u00a0\n <\/p>\n